Adaptive Biotechnologies
ADPT
ADPT
241 hedge funds and large institutions have $1.73B invested in Adaptive Biotechnologies in 2025 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 93 increasing their positions, 63 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
48% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 63
7% more funds holding
Funds holding: 225 → 241 (+16)
5.39% less ownership
Funds ownership: 102.93% → 97.54% (-5.4%)
Holders
241
Holding in Top 10
2
Calls
$2.39M
Puts
$321K
Top Buyers
| 1 | +$27.4M | |
| 2 | +$16.7M | |
| 3 | +$16M | |
| 4 |
CCM
Catalio Capital Management
New York
|
+$9.14M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$8.46M |
Top Sellers
| 1 | -$79.9M | |
| 2 | -$43.3M | |
| 3 | -$39.6M | |
| 4 |
Millennium Management
New York
|
-$23.1M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$20.8M |
